Transplantation for the millenniumattaining tolerance in our time - The holy grail

Seminars in Nephrology

Volumn 20, Issue 1, 2000, Pages 83-86

  Helderman, J Harold ^a,b   Goral, Simin ^a  

^a Vanderbilt University Transplant Center   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; T LYMPHOCYTE RECEPTOR;

CHIMERA; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TIME FACTORS;

EID: 0033978647     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rosengard BR, Ojikutu CA, Guzzetta PC, et al: Induction of specific tolerance to class I disparate renal allografts in miniature swine with cyclosporine. Transplantation 54:490-497, 1992
2. Yamada K, Gianello PR, lerino FL, et al: Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med 186:497-506, 1997
3. Yamada K, lerino FL, Gianello PR, et al: Role of the thymus in transplantation tolerance in miniature swine. Surgical manipulation of the thymus interferes with stable induction of tolerance to class I-mismatched renal allografts. Transplantation 67:1112-1119, 1999
4. Lenschow D, Zeng Y, Thistlethwaite J, et al: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-Ig. Science 257:789-792, 1992
5. Pearson TC, Alexander DZ, Winn KJ, et al: Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701-1706, 1994
6. Yang Z, Rostami S, Koeberlein B, et al: Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig. Transplantation 67:1517-1523, 1999
7. Knechtle SJ, Kirk AD, Fechner JH, et al: Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA-Ig, and anti-CD40 ligand. Transplant Proc 31:27S-28S, 1999
8. Plain KM, Chen J, Merten S, et al: Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody. Transplantation 67:605-613, 1999
9. Lazarovits AI, Poppema S, White MJ, et al: Inhibition of alloreactivity in vitro by monoclonal antibodies directed against restricted isoforms of the leukocyte-common antigen (CD45). Transplantation 54:724-729, 1992
10. Gao Z, Zhong R, Jiang J, et al: Adoptively transferable tolerance induced by CD45RB monoclonal antibody. J Am Soc Nephrol 10:374-381, 1999
11. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172:603-608, 1953
12. Starzl TE, Demetris AJ, Trucco M, et al: Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 328:745-749,1993
13. Yang L, DuTempIe B, Khan Q, et al: Mechanisms of long-term donor-specific allograft survival induced by pretransplant infusion of lymphocytes. Blood 91:324-330, 1998
14. Mayfield RS, Hayashi H, Sawada T, et al: The mechanism of specific prolongation of class I-mismatched skin grafts induced by retroviral gene therapy. Eur J Immunol 27:1177-1181, 1997
15. Van Twuyver E, Mooijaart RJD, ten Berge JM, et al: Pretransplant blood transfusion revisited revisited. N Engl J Med 325:1210-1213, 1991
16. Yang L, DuTempIe B, Gorczynski RM, et al: Evidence for epitope spreading and active suppression in skin graft tolerance after donor specific transfusion. Transplantation 67: 1404-1410, 1999
17. Sayegh MH, Perico N, Gallon L, et al: Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 58:125-132, 1994
18. Sayegh MH, Krensky AM: Novel immunotherapeutic strategies using MHC derived peptides. Kidney Int 49:S13-S20, 1996 (suppl 53)